Long-term survivor characteristics in HER2-positive metastatic breast cancer from registHER

Bằng Yardley, D A, Tripathy, D, Brufsky, A M, Rugo, H S, Kaufman, P A, Mayer, M, Magidson, J, Yoo, B, Quah, C, Ulcickas Yood, M
Được phát hành 2014

nab-Paclitaxel plus carboplatin or gemcitabine versus gemcitabine plus carboplatin as first-line treatment of patients with triple-negative metastatic breast cancer: results from t...

Bằng Yardley, D A, Coleman, R, Conte, P, Cortes, J, Brufsky, A, Shtivelband, M, Young, R, Bengala, C, Ali, H, Eakel, J, Schneeweiss, A, de la Cruz-Merino, L, Wilks, S, O’Shaughnessy, J, Glück, S, Li, H, Miller, J, Barton, D, Harbeck, N
Xuất bản năm Ann Oncol (2018)

The immune profile of small HER2-positive breast cancers: a secondary analysis from the APT trial

Bằng Barroso-Sousa, R., Barry, W.T., Guo, H., Dillon, D., Tan, Y.B., Fuhrman, K., Osmani, W., Getz, A., Baltay, M., Dang, C., Yardley, D., Moy, B., Marcom, P.K., Mittendorf, E.A., Krop, I.E., Winer, E.P., Tolaney, S.M.
Xuất bản năm Ann Oncol (2019)